Clinical Trial Update: The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial update evaluating oral 9-cis beta-carotene-rich powder from the alga Dunaliella bardawil in individuals with retinitis pigmento…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• 9-cis beta-carotene-rich powder from Dunaliella bardawil (9-cis beta-carotene)

Snippet

Sponsor: Sheba Medical Center | Conditions: Retinitis Pigmentosa | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING